BioAmber’s Mission? To be a fast growing producer of chemical intermediates that uses sugars instead of fossil fuels and sells competitively priced, sustainable chemicals with strong profit margins and the cleanest environmental footprint in the industry. The latest? “We are pleased to report our second quarter 2017 results generated BioAmber’s largest quarterly revenue ever. Year to […]
Santa Claus rallies typically occur between Christmas and New Year’s. But industrial biotech’s rally came early this year. Who is up, and why? The Digest investigates. If you’ve been following The Digest’s Equity Index in recent weeks, you’ll note that it has rallied just on 8 percent in the past two weeks, after hitting a […]
In Minnesota, BioAmber announced a net loss of $9.0 million, or $0.48 per share, for the three months ended September 30, 2013, compared to $11.6 million, or $1.12 per share, for the three months ended September 30, 2012. Highlights including achieving the final development milestone for the yeast licensed exclusively from Cargill, sales of $866,000 […]
